CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance

Clinical trial NCT07643493 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07643493
Sponsor: David Dornbos
Status: ENROLLING_BY_INVITATION
Phase: Phase 4
Study type: INTERVENTIONAL

Tissue Plasminogen Activator Intraventricular Brain Hemorrhage

Start date: 2026-07-31
Primary completion: 2028-05-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.